SCHEMBL45359

SCHEMBL45359

c1ccc(-c2ncc3ccccc3n2)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.57
TDP1 Q9NUW8 3/20 0.57
CYP1A2 P05177 4/20 0.53
METAP1 P53582 2/20 0.53
TP53 P04637 4/20 0.52
L3MBTL1 Q9Y468 4/20 0.48
ALOX15 P16050 3/20 0.48
POLB P06746 2/20 0.48
LMNA P02545 2/20 0.48
CCR1 P32246 2/20 0.48
CCR5 P51681 2/20 0.48
CCR8 P51685 2/20 0.48
BLM P54132 1/20 0.48
HIF1A Q16665 1/20 0.48
DOHH Q9BU89 1/20 0.48
P4HTM Q9NXG6 1/20 0.48
ALDH1A1 P00352 4/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HTT P42858 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29784044 1.00 KDM4E (0.57) KDM4ETDP1CYP1A2METAP1TP53
SCHEMBL11329633 0.82 CYP1A2 (0.58) KDM4ETDP1CYP1A2METAP1LMNA
SCHEMBL28802825 0.81 CYP1A2 (0.54) KDM4ECYP1A2METAP1L3MBTL1POLB
SCHEMBL1672650 0.81 CYP1A2 (0.60) KDM4ECYP1A2LMNAALDH1A1MAPT
SCHEMBL30527184 0.81 CYP1A2 (0.60) KDM4ECYP1A2LMNAALDH1A1MAPT
SCHEMBL30198446 0.81 CYP1A2 (0.60) KDM4ECYP1A2LMNAALDH1A1MAPT
SCHEMBL26674905 0.80 L3MBTL1 (0.51) KDM4ETDP1CYP1A2METAP1TP53
SCHEMBL8515946 0.80 KDM4E (0.43) KDM4ETDP1CYP1A2METAP1TP53
SCHEMBL8515328 0.80 GRM5 (0.59) KDM4ETDP1CYP1A2METAP1TP53
SCHEMBL28091206 0.78 CYP1A2 (0.50) KDM4ETDP1CYP1A2TP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111704604-B Preparation method of pyridine quinazoline 湖南速博生物技术有限公司 2020-11-17 CN claimed
CN-111704604-A Preparation method of pyridine quinazoline 湖南速博生物技术有限公司 2020-09-25 CN claimed
EP-1966184-B1 PYRIDINYL-QUINAZOLINE DERIVATIVES AND THEIR MEDICAL USE NEUROSEARCH AS (DK) 2010-08-25 EP claimed
US-20090306102-A1 2-PYRIDIN-2-YL-QUINAZOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATING AGENTS FOR THE TREATMENT OF RESPIRATORY DISEASES NEUROSEARCH A/S (DK) 2009-12-10 US claimed
EP-1966184-A2 PYRIDINYL-QUINAZOLINE DERIVATIVES AND THEIR MEDICAL USE NeuroSearch A/S (DK) 2008-09-10 EP claimed
WO-2007071632-A2 2-PYRIDIN-2-YL-QUINAZOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATING AGENTS FOR THE TREATMENT OF RESPIRATORY DISEASES NEUROSEARCH A/S (DK) 2007-06-28 WO claimed
US-4764454-A Color photographic material with color forming ligand compounds and a method of processing FUJI PHOTO FILM CO., LTD. (JP) 1988-08-16 US claimed
CN-116987076-A 1,2, 4-triazolo [4,3-a ] pyridine sulfone derivative, and preparation method and application thereof 贵州大学 2023-11-03 CN disclosed
CN-113519536-A Binary compound insecticidal composition 合肥巨卓农业科技合伙企业(有限合伙) 2021-10-22 CN disclosed
CN-113508817-A Insecticidal composition of pyridine quinazoline and diazinon 黑龙江巨卓作物科学有限公司 2021-10-19 CN disclosed
CN-113475510-A Binary compound insecticidal composition containing pyridine quinazoline 黑龙江巨卓作物科学有限公司 2021-10-08 CN disclosed
CN-111887255-A Pesticide composition containing spiromesifen and pyridine quinazoline and application thereof 山东康乔生物科技有限公司 2020-11-06 CN disclosed
CN-111184034-A Pesticide composition containing pyridine quinazoline and eucalyptol 江西中迅农化有限公司 2020-05-22 CN disclosed
EP-0186870-A2 Photographic elements and processes utilizing imagewise reduction of ferric ions EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-09 EP disclosed
EP-0186869-A2 Colorless ligand-releasing monomers and polymers and their use to provide dyes with metal ions EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-09 EP disclosed
EP-0186868-A2 Photographic element and process for providing metal complex color images EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1986-07-09 EP disclosed
US-4568633-A THEN REACTING WITH COMPLEXING COMPOUND TO FORM DYE EASTMAN KODAK COMPANY (US) 1986-02-04 US disclosed
US-4557998-A AVOIDS COUPLER SOLVENTS EASTMAN KODAK COMPANY (US) 1985-12-10 US disclosed
US-4555478-A Photographic element and process for providing metal complex color images EASTMAN KODAK COMPANY (US) 1985-11-26 US disclosed
US-4555477-A Photographic element and process utilizing metal complex color masking dyes EASTMAN KODAK COMPANY (US) 1985-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090306102-A1 2-PYRIDIN-2-YL-QUINAZOLINE DERIVATIVES AS POTASSIUM CHANNEL MODULATING AGENTS FOR THE TREATMENT OF RESPIRATORY DISEASES KCNJ2, KCNQ1, KCNK2 KDM4E 1023/4885TDP1 3156/4885CYP1A2 1530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.